Showing results (371-380 of 489) with videos related to

Sort By:
Pageof 49
American Journal of Medical Genetics. Part A|February 24, 2011
Cantú syndrome: report of nine new cases and expansion of the clinical phenotypeIngrid Scurr, Louise Wilson, Melissa Lees, et al.
The Journal of Investigative Dermatology|February 14, 2002
Netherton syndrome: disease expression and spectrum of SPINK5 mutations in 21 familiesEmmanuelle Bitoun, Stéphane Chavanas, Alan D Irvine, et al.
JAMA Dermatology|February 1, 2023
Efficacy and Safety of Dupilumab in Patients With Erythrodermic Atopic Dermatitis: A Post Hoc Analysis of 6 Randomized Clinical TrialsAmy S Paller, Jonathan I Silverberg, Michael J Cork, et al.
Science Advances|September 3, 2025
Ultrastrong Staphylococcus aureus adhesion to human skin: Calcium as a key regulator of noncovalent interactionsConstance Chantraine, Priscila S F C Gomes, Marion Mathelié-Guinlet, et al.
Dermatology and Therapy|July 30, 2026
Achieving Minimal Disease Activity in Atopic Dermatitis Is Associated with Fewer Flares, Reduced Healthcare Resource Utilization, and Improved Disease Control: Analysis from the Real-World MEASURE-AD StudyJonathan I Silverberg, Vimal H Prajapati, Susanne Abraham, et al.
The British Journal of Dermatology|September 3, 2017
Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statementA M Drucker, K Eyerich, M S de Bruin-Weller, et al.
The Journal of Allergy and Clinical Immunology|July 13, 2010
Raman profiles of the stratum corneum define 3 filaggrin genotype-determined atopic dermatitis endophenotypesGráinne M O'Regan, Patrick M J H Kemperman, Aileen Sandilands, et al.
Plos One|December 17, 2011
Development of allele-specific therapeutic siRNA in Meesmann epithelial corneal dystrophyHaihui Liao, Alan D Irvine, Caroline J Macewen, et al.
Development (Cambridge, England)|July 31, 2019
Dchs1-Fat4 regulation of osteogenic differentiation in mouseIvan Crespo-Enriquez, Tina Hodgson, Sana Zakaria, et al.
Dermatology and Therapy|June 18, 2026
Three-Year Efficacy and Safety of Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Long-Term Extension (ADjoin)Emma Guttman-Yassky, Alan D Irvine, Melinda Gooderham, et al.
Pageof 49